Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of oral Deuremidevir Hydrobromide for Suspension has been completed in participants wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Drugs mentioned

• Deuremidevir Hydrobromide for Suspension (Deuremidevir Hydrobromide)

Snippet

Sponsor: Vigonvita Life Sciences | Conditions: Respiratory Syncytial Virus Infections | Phase 1 | Status: COMPLETED